Progress on haptoglobin and metabolic diseases

doi:10.4239/wjd.v12.i3.206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6065)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

388

WORD

178

HTML

4342

Figures (1-3)

378

Sum=5286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

340

Download

439

Sum=779

Mar 15, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Diabetes. Mar 15, 2021; 12(3): 206-214
Published online Mar 15, 2021. doi: 10.4239/wjd.v12.i3.206

Full Size Figure Download Figure

Figure 3 Prediction analysis of human serum haptoglobin-interacting proteins. APOE: Apolipoprotein E; HBA: Hemoglobin subunit alpha; HP: Haptoglobin; LRG1: Leucine-rich-alpha-2-glycoprotein 1; LTF: Lactotransferrin; ORM: Orosomucoid.

Citation: Wan BN, Zhou SG, Wang M, Zhang X, Ji G. Progress on haptoglobin and metabolic diseases. World J Diabetes 2021; 12(3): 206-214
URL: https://www.wjgnet.com/1948-9358/full/v12/i3/206.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i3.206